Technetium Tc-99m medronate

DB09138ApprovedInvestigationalSmall moleculeRadioactive Diagnostic Agent

Technetium Tc-99m medronate is a diagnostic radiopharmaceutical agent used as a bone imaging agent to delineate areas of altered osteogenesis. Technetium (99mTc) medronic acid is a pharmaceutical product used in nuclear medicine imaging.

Chemical structure of Technetium Tc-99m medronate
Mechanism
Curator reviewed
Primary indication
Technetium Tc 99m Medronate is indicated for use as a bone imaging agent to delineate areas of altered osteogenesis.Curator reviewed · 1 structured indication
Formula / weight
CH6O8P2Tc · 305.906 g/mol (avg)
First approval
United States, 1979
Also known as
99m Tc medronate · 99m Tc-medronate · 99mTc medronate · 99mTc-medronate · AN-MDP

Resolves to

Compound
UNIIX89XV46R07CAS121524-79-6ChEMBLCHEMBL2110576ChEBI32186PubChem131704315KEGGD02029
Clinical / RWD
RxNorm1488818ATCV09BA02
Structure
InChIKeyIUPNVOAUFBLQME-SGNQUONSSA-JSMILESO.O.[98Tc+4].[O-]P([O-])(=O)CP([O-])([O-])=O

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
3Marketed productsAcross 1 country and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 14 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Technetium Tc-99m medronate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In